|
|
Article: Findings may pave way to better antirejection treatment.
- Article from:
- Immunotherapy Weekly
- Article date:
- July 30, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 JUL 30 - (NewsRx.com & NewsRx.net) -- A simple test may pinpoint children at high risk of rejecting newly transplanted kidneys, say researchers at Lucile Packard Children's Hospital and the Stanford School of Medicine.
The research, which also identifies more than one type of acute rejection, may increase the long-term survival of transplant patients and reduce the severe side effects caused by common antirejection drugs.
Acute rejection affects 15-40% of kidney transplant recipients nationwide and is a leading cause of retransplantation or death in these patients. Although the tissue inflammation and cell damage that spell trouble for a ...